Shares of Xometry, Inc. (NASDAQ:XMTR – Get Free Report) have received a consensus rating of “Hold” from the seven analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $22.14.
A number of brokerages have issued reports on XMTR. Cantor Fitzgerald cut their price objective on shares of Xometry from $13.00 to $12.00 and set an “underweight” rating for the company in a report on Friday, August 9th. JMP Securities reaffirmed a “market outperform” rating and set a $27.00 price objective on shares of Xometry in a report on Thursday, September 19th.
Xometry Price Performance
Xometry (NASDAQ:XMTR – Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.13. Xometry had a negative net margin of 10.53% and a negative return on equity of 10.75%. The business had revenue of $132.60 million during the quarter, compared to analyst estimates of $128.65 million. During the same period last year, the firm posted ($0.55) EPS. The company’s revenue was up 19.5% on a year-over-year basis. As a group, research analysts anticipate that Xometry will post -0.81 earnings per share for the current year.
Insider Activity at Xometry
In related news, CTO Matthew Leibel sold 3,400 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $18.45, for a total value of $62,730.00. Following the sale, the chief technology officer now directly owns 82,918 shares of the company’s stock, valued at $1,529,837.10. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 16.79% of the stock is currently owned by insiders.
Institutional Trading of Xometry
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Sei Investments Co. raised its position in Xometry by 0.8% in the 2nd quarter. Sei Investments Co. now owns 214,048 shares of the company’s stock worth $2,474,000 after purchasing an additional 1,708 shares during the period. State Board of Administration of Florida Retirement System grew its stake in Xometry by 22.1% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 11,840 shares of the company’s stock worth $200,000 after acquiring an additional 2,140 shares in the last quarter. nVerses Capital LLC bought a new position in Xometry in the 2nd quarter worth about $38,000. Rhumbline Advisers grew its stake in Xometry by 6.8% in the 2nd quarter. Rhumbline Advisers now owns 58,002 shares of the company’s stock worth $670,000 after acquiring an additional 3,690 shares in the last quarter. Finally, ProShare Advisors LLC bought a new position in Xometry in the 2nd quarter worth about $53,000. 97.31% of the stock is owned by hedge funds and other institutional investors.
About Xometry
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Featured Stories
- Five stocks we like better than Xometry
- What is the S&P/TSX Index?
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Investing in Construction Stocks
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.